Investigational Site 012 — Salt Lake City, Utah

Investigational Site 012 is a clinical research site located in Salt Lake City, Utah, United States 84112.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Investigational Site 012 has participated in 1 clinical trials.

Therapeutic areas: Malignant Melanoma.

Sponsors: AmpliMed Corporation.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site 012?

Investigational Site 012 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site 012 conducted?

Investigational Site 012 has 1 clinical trials on record. Their work covers Malignant Melanoma.

Is Investigational Site 012 accredited by Crixeo Health?

Investigational Site 012 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site 012?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.